Sbir phase I: a thermogel-based drug delivery platform for the upper gastrointestinal bleeding treatment
Ended Project Grant Awarded Last action
- Award ID
- 2014730
- Recipient
-
Intact Therapeutics UEI ZYZ1FU7HBU73
- Awarding agency
-
National Science Foundation
- Obligated
- $244,999
Award facts
- Assistance listing
- 47.084 NSF Technology, Innovation, and Partnerships
- Completion date
- Originally
- Place of performance
- Hayward, CA 94545, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $20,000 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $224,999 |
Quick answers
Who received award 2014730?
2014730 was awarded to Intact Therapeutics by National Science Foundation on August 15, 2020.
How much is award 2014730 worth?
$244,999 has been obligated on 2014730.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award